The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma. [electronic resource]
Producer: 20151217Description: e89449 p. digitalISSN:- 1932-6203
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- genetics
- Carcinoma, Renal Cell -- drug therapy
- Disease Models, Animal
- Drug Resistance, Neoplasm
- Female
- Gene Expression
- Humans
- Indoles -- pharmacology
- Kidney Neoplasms -- drug therapy
- Mice
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Neoplasm Staging
- Neovascularization, Pathologic -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- pharmacology
- Precision Medicine
- Pyrroles -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Sorafenib
- Sunitinib
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.